Geron

About:

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies.

Top Investors: Hercules Capital, OrbiMed, RA Capital Management, New Enterprise Associates, Deep Track Capital

Description:

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.

Total Funding Amount:

$1B

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Foster City, California, United States

Founded Date:

1990-08-28

Contact Email:

info(AT)geron.com

Founders:

Alex Barkas, Michael D West